Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry
Michel Komajda, Martín Cowie, Luigi Tavazzi, et al.
European Journal of Heart Failure (2017) Vol. 19, Iss. 11, pp. 1414-1423
Open Access | Times Cited: 223

Showing 1-25 of 223 citing articles:

Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology
María G. Crespo‐Leiro, Marco Metra, Lars H. Lund, et al.
European Journal of Heart Failure (2018) Vol. 20, Iss. 11, pp. 1505-1535
Open Access | Times Cited: 727
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology
Petar Seferović, Piotr Ponikowski, Stefan D. Anker, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 10, pp. 1169-1186
Open Access | Times Cited: 580
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018
J. Atherton, Andrew Sindone, Carmine G. De Pasquale, et al.
Heart Lung and Circulation (2018) Vol. 27, Iss. 10, pp. 1123-1208
Open Access | Times Cited: 362
2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology
Russian Journal of Cardiology (2020) Vol. 25, Iss. 11, pp. 4083-4083
Open Access | Times Cited: 335
Heart failure drug treatment
Patrick Rossignol, Adrian F. Hernandez, Scott D. Solomon, et al.
The Lancet (2019) Vol. 393, Iss. 10175, pp. 1034-1044
Open Access | Times Cited: 294
Highlights in heart failure
Daniela Tomasoni, Marianna Adamo, Carlo Lombardi, et al.
ESC Heart Failure (2019) Vol. 6, Iss. 6, pp. 1105-1127
Open Access | Times Cited: 214
Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018
Alexander C. Fanaroff, Robert M. Califf, Stephan Windecker, et al.
JAMA (2019) Vol. 321, Iss. 11, pp. 1069-1069
Open Access | Times Cited: 188
Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction
Hans‐Peter Brunner‐La Rocca, Gerard C.M. Linssen, Frank J. Smeele, et al.
JACC Heart Failure (2018) Vol. 7, Iss. 1, pp. 13-21
Open Access | Times Cited: 162
Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden)
Gianluigi Savarese, Johan Bodegård, Anna Norhammar, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 9, pp. 1499-1511
Open Access | Times Cited: 138
Physicians' guideline adherence is associated with long‐term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry
Michel Komajda, Jakob Schöpe, Stefan Wagenpfeil, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 7, pp. 921-929
Open Access | Times Cited: 114
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA‐EORP Heart Failure Long‐Term Registry
Patrick Rossignol, Mitja Lainščak, María G. Crespo‐Leiro, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 8, pp. 1378-1389
Open Access | Times Cited: 111
Telemedical Interventional Management in Heart Failure II (TIM‐HF2), a randomised, controlled trial investigating the impact of telemedicine on unplanned cardiovascular hospitalisations and mortality in heart failure patients: study design and description of the intervention
Friedrich Koehler, Kerstin Koehler, Oliver Deckwart, et al.
European Journal of Heart Failure (2018) Vol. 20, Iss. 10, pp. 1485-1493
Open Access | Times Cited: 100
2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology
Russian Journal of Cardiology (2020) Vol. 25, Iss. 11, pp. 4083-4083
Open Access | Times Cited: 88
Clinical inertia in the treatment of heart failure: a major issue to tackle
Caroline Verhestraeten, Ward Heggermont, Michael B. Maris
Heart Failure Reviews (2020) Vol. 26, Iss. 6, pp. 1359-1370
Open Access | Times Cited: 75
Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care
Daniela Tomasoni, Julie K.K. Vishram‐Nielsen, Matteo Pagnesi, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 3, pp. 1507-1523
Open Access | Times Cited: 51
Impact analysis of heart failure across European countries: an ESC‐HFA position paper
Giuseppe Rosano, Petar Seferović, Gianluigi Savarese, et al.
ESC Heart Failure (2022) Vol. 9, Iss. 5, pp. 2767-2778
Open Access | Times Cited: 46
Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction
Jasper Tromp, Wouter Ouwerkerk, Tiew‐Hwa Katherine Teng, et al.
European Heart Journal (2022) Vol. 43, Iss. 23, pp. 2224-2234
Open Access | Times Cited: 42
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration
Marianna Adamo, Daniela Tomasoni, Lukas Stolz, et al.
КАРДИОЛОГИЯ УЗБЕКИСТАНА (2023) Vol. 16, Iss. 8, pp. 896-905
Open Access | Times Cited: 35
Guideline‐directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP‐HF registry
Daniela Tomasoni, Matteo Pagnesi, Giada Colombo, et al.
European Journal of Heart Failure (2023) Vol. 26, Iss. 2, pp. 327-337
Open Access | Times Cited: 24
Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia
Eiichiro Kanda, Anjay Rastogi, Toyoaki Murohara, et al.
BMC Nephrology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 23
The Effect of Using a Remote Patient Management Platform in Optimizing Guideline-Directed Medical Therapy in Heart Failure Patients
Darshan H. Brahmbhatt, Heather J. Ross, Mary P. O’Sullivan, et al.
JACC Heart Failure (2024) Vol. 12, Iss. 4, pp. 678-690
Open Access | Times Cited: 9
Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC
Hadi Skouri, Nicolas Girerd, Luca Monzo, et al.
European Journal of Heart Failure (2025)
Closed Access | Times Cited: 1
Association Between Medication Adherence and the Outcomes of Heart Failure
Sarah R. Hood, Anthony J. Giazzon, Gwen Seamon, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2018) Vol. 38, Iss. 5, pp. 539-545
Open Access | Times Cited: 74
Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK
Cecilia Linde, Lei Qin, Ameet Bakhai, et al.
ESC Heart Failure (2019) Vol. 6, Iss. 2, pp. 280-290
Open Access | Times Cited: 74
Real‐World Associations of Renin–Angiotensin–Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New‐Onset Chronic Kidney Disease or Heart Failure in the United Kingdom
Cecilia Linde, Ameet Bakhai, Hans Furuland, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 22
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top